Contrast Media Injectors Market to Grow to $2.32 Billion by 2028 within Forecast Period 2024-2033, Fueled by Rising Interventional Radiology Procedures

The contrast media injectors market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased incidence of chronic diseases, increased diagnostic imaging procedures, demand for minimally invasive procedures, expansion of healthcare infrastructure, growing aging population.

The contrast media injectors market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rise in interventional radiology procedures, increasing prevalence of cancer, focus on patient safety and comfort, globalization of healthcare services, regulatory support and compliance. Major trends in the forecast period include automation and connectivity, emergence of dual-head injectors, advancements in injector technology, focus on patient safety, rise in interventional radiology procedures, enhanced imaging techniques and modalities.

Market Overview -
Contrast media injectors refer to medical devices that are used for injecting contrast media into the body to enhance the visibility of tissues for medical imaging procedures. It provides high accuracy, precision, and better outcomes during surgical procedures.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10187&type=smp

Increasing Cancer And Cardiovascular Disease Incidences Contrast Media Injectors Market Expands Amidst
Increasing cancer and cardiovascular disease (CVD) are expected to propel the growth of the contrast media injectors market going forward. Cancer is a condition that occurs when body cells grow out of control and spread to other body regions. Cardiovascular disease refers to a type of disease that affects the heart or blood vessels. Contrast media injectors are applied while diagnostic imaging to enhance image quality and patient safety and improve blood flow and tissue perfusion. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. , Furthermore, in April 2023, according to the World Heart Federation, a Switzerland-based non-governmental organization, over 500 million individuals worldwide will remain impacted by cardiovascular diseases. These conditions led to 20.5 million fatalities in 2021, representing nearly one-third of the total global mortality and reflecting a notable rise from the previously estimated 121 million deaths attributed to cardiovascular diseases. Therefore, increasing cancer and cardiovascular disease (CVD) are driving the growth of the contrast media injectors market.

Competitive Landscape -
Major companies operating in the contrast media injectors market report are The Bracco Group, Bayer AG, Medtron AG, Ulrich GmbH And Co. KG, General Electric Company, Nemoto Kyorindo Co. Ltd., Guerbet Group, Sino Medical-Device Technology Co. Ltd, Apollo RT Co.Ltd, Shenzhen Anke High-tech Co. Ltd, Hilin Life Products Inc., Sanofi S.A, Novartis AG, Vivid Imaging, AngioDynamics. Inc., Taejoon Pharmaceutical Co. Ltd., Hong Kong Medi Co Limited, Medrad Inc., TaeWoong Medical Co. Ltd., Medtronic Plc, Covidien, ACIST Medical Systems, Boston Scientific Corporation, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Imaxeon Pty Ltd., Nano-Ditech Corp.

Strategic Partnerships Propel Advancements In The Contrast Media Injectors Market
Strategic partnerships are a key trend gaining popularity in contrast media injectors market. Major companies operating in the contrast media injectors market are forming partnerships to develop a new type of relationship in which two or more organizations have similar product developments. For instance, in December 2022, Qaelum NV, a Belgium-based advanced dose and contrast management software solutions company, partnered with Ulrich GmbH & Company KG., a France-based manufacturer and distributor of surgical instruments. With this partnership, the companies aim to combine their advanced contrast management solution with the contrast media injectors of Ulrich Medical to support the needs of hospitals and imaging networks. Furthermore, in December 2021, Bracco Group, an Italy-based healthcare company, announced a partnership with Guerbet, a France-based manufacturer of contrast agents. This partnership aim is to develop Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent and to strengthen expertise and investigate untapped areas of research in pursuit of an agent that would enable early identification and provide significant health advantages.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/contrast-media-injectors-global-market-report

Key Segments -
The contrast media injectors market covered in this report is segmented -
1) By Product: Consumables, Injector Systems, Accessories
2) By Type of Injectors: Single Head Injectors, Dual-Head Injectors, Syringe less Injectors
3) By Application: Radiology, Interventional Cardiology, Interventional Radiology
4) By End-user: Hospitals, Diagnostics Centers, Ambulatory Surgery Centers

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.